IBJNews

WellPoint to sell subsidiary for $4.6B

Back to TopCommentsE-mailPrintBookmark and Share
 WellPoint Inc. has agreed to sell its pharmacy benefits management arm for $4.675 billion in cash and stock to St. Louis-based Express Scripts, the companies announced this morning.

Indianapolis-based WellPoint is the nation's second-largest health insurer, covering 35 million individuals.

WellPoint's pharmacy subsidiaries, called NextRx, dispense and manage 265 million prescriptions each year for 25 million people.

As part of the sale, Express Scripts has agreed to a 10-year contract to provide services to WellPoint.

"Importantly, through this strategic alliance with Express Scripts, we will enhance the health care value we bring to our members," said WellPoint CEO Angela Braly. "This alliance will create an organization with greater resources and capabilities, which will provide members with more cost-effective solutions as well as access to state-of-the-art [pharmacy management] services."

WellPoint will retain control of medical policy, formulary and integrated disease management aspects of its pharmacy benefits.

The deal is expected to close in the second half of 2009. Express Scripts will pay WellPoint $3.275 billion in cash and $1.4 billion in stock. The deal also includes compensation for the value of a future tax benefit for Express Scripts based on the structure of the deal.
ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT